100 research outputs found
The Generalized Stochastic Microdosimetric Model: the main formulation
The present work introduces a rigorous stochastic model, named Generalized
Stochastic Microdosimetric Model (GSM2), to describe biological damage induced
by ionizing radiation. Starting from microdosimetric spectra of energy
deposition in tissue, we derive a master equation describing the time evolution
of the probability density function of lethal and potentially lethal DNA damage
induced by radiation in a cell nucleus. The resulting probability distribution
is not required to satisfy any a priori assumption. Furthermore, we generalized
the master equation to consider damage induced by a continuous dose delivery.
In addition, spatial features and damage movement inside the nucleus have been
taken into account. In doing so, we provide a general mathematical setting to
fully describe the spatiotemporal damage formation and evolution in a cell
nucleus. Finally, we provide numerical solutions of the master equation
exploiting Monte Carlo simulations to validate the accuracy of GSM2.
Development of GSM2 can lead to improved modeling of radiation damage to both
tumor and normal tissues, and thereby impact treatment regimens for better
tumor control and reduced normal tissue toxicities
Cancer stem cells display extremely large evolvability alternating plastic and rigid networks as a potential mechanism Network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence
Cancer is increasingly perceived as a systems-level, network phenomenon. The major trend of malignant transformation can be described as a two-phase process, where an initial increase of network plasticity is followed by a decrease of plasticity at late stages of tumor development. The fluctuating intensity of stress factors, like hypoxia, inflammation and the either cooperative or hostile interactions of tumor inter-cellular networks, all increase the adaptation potential of cancer cells. This may lead to the bypass of cellular senescence, and to the development of cancer stem cells. We propose that the central tenet of cancer stem cell definition lies exactly in the indefinability of cancer stem cells. Actual properties of cancer stem cells depend on the individual "stress-history" of the given tumor. Cancer stem cells are characterized by an extremely large evolvability (i.e. a capacity to generate heritable phenotypic variation), which corresponds well with the defining hallmarks of cancer stem cells: the possession of the capacity to self-renew and to repeatedly re-build the heterogeneous lineages of cancer cells that comprise a tumor in new environments. Cancer stem cells represent a cell population, which is adapted to adapt. We argue that the high evolvability of cancer stem cells is helped by their repeated transitions between plastic (proliferative, symmetrically dividing) and rigid (quiescent, asymmetrically dividing, often more invasive) phenotypes having plastic and rigid networks. Thus, cancer stem cells reverse and replay cancer development multiple times. We describe network models potentially explaining cancer stem cell-like behavior. Finally, we propose novel strategies including combination therapies and multi-target drugs to overcome the Nietzschean dilemma of cancer stem cell targeting: "what does not kill me makes me stronger"
- …